JT
XERS icon

Jupiter Topco’s Xeris Biopharma Holdings XERS Stock Holding History

Jupiter Topco’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.29M Buy
+414,959
New +$2.65M ﹤0.01% 1237

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jupiter Topco's XERS Position: Q2 2026 in Review

Jupiter Topco opened a new position in Xeris Biopharma Holdings (XERS) in Q2 2026: 414,959 shares worth $3.29M. The stake represents ﹤0.01% of the portfolio and ranks #1237 among its holdings.

217 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Jupiter Topco held 414,959 shares of Xeris Biopharma Holdings worth $3.29M as of Q2 2026.
  • Xeris Biopharma Holdings was a new Jupiter Topco position in Q2 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #1237 holding.
  • 217 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.